NOT  FOR RELEASE, PUBLICATION OR  DISTRIBUTION, IN WHOLE OR  IN PART DIRECTLY OR
INDIRECTLY,  IN  AUSTRALIA,  CANADA,  JAPAN  OR  THE  UNITED  STATES  OR ANOTHER
JURISDICTION  IN  WHICH  THE  RELEASE,  PUBLICATION  OR  DISTRIBUTION  WOULD  BE
UNLAWFUL.  THIS  ANNOUNCEMENT  DOES  NOT  CONSTITUTE  AN  OFFER  OF  ANY  OF THE
SECURITIES DESCRIBED HEREIN.

Reference  is made  to the  stock exchange  announcement by  Hofseth Biocare ASA
("HBC"   or  the  "Company")  on  27 October  2025 relating  to  a  contemplated
subsequent  offering  of  up  to  16,666,666 new shares directed towards certain
eligible shareholders (the "Subsequent Offering").

Subject to the Subsequent Offering being resolved carried out, the shares in the
Company  will be  traded exclusive  the right  to participate  in the Subsequent
Offering as from today, 27 October 2025.

Advisor

Advokatfirmaet CLP DA is acting as legal advisor to the Company.

For further information, please contact:

Jon Olav Ødegård, CEO at HBC
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no (mailto:joo@hofsethbiocare.no)

***

Important information

This  announcement is not and  does not form a  part of any offer  to sell, or a
solicitation of an offer to purchase, any securities of the Company.

Copies  of this announcement  are not being  made and may  not be distributed or
sent into any jurisdiction in which such distribution would be unlawful or would
require  registration  or  other  measures.  The  securities referred to in this
announcement  have not been and will not be registered under the U.S. Securities
Act  of  1933, as  amended  (the  "Securities  Act"), and accordingly may not be
offered  or  sold  in  the  United  States  absent registration or an applicable
exemption  from  the  registration  requirements  of  the  Securities Act and in
accordance with applicable U.S. state securities laws. The Company do not intend
to register any part of the Offering in the United States or to conduct a public
offering  of securities in the  United States. Any sale  in the United States of
the  securities mentioned in this announcement will be made solely to "qualified
institutional buyers" as defined in Rule 144A under the Securities Act.

In  any EEA Member  State, this communication  is only addressed  to and is only
directed  at qualified investors in that Member  State within the meaning of the
Prospectus Regulation, i.e., only to investors who can receive the offer without
an  approved prospectus  in such  EEA Member  State. The "Prospectus Regulation"
means  Regulation  (EU)  2017/1129, as  amended  (together  with  any applicable
implementing measures) in any Member State.

This  communication is only being distributed to and is only directed at persons
in  the  United  Kingdom  that  are  (i) investment professionals falling within
Article   19(5) of  the  Financial  Services  and  Markets  Act  2000 (Financial
Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities,
and  other  persons  to  whom  this  announcement  may lawfully be communicated,
falling  within Article 49(2)(a) to (d) of  the Order (all such persons together
being  referred to as "relevant persons").  This communication must not be acted
on  or relied  on by  persons who  are not  relevant persons.  Any investment or
investments  activity to which this communication  relates is available only for
relevant  persons and  will be  engaged in  only with  relevant persons. Persons
distributing  this communication must satisfy themselves that it is lawful to do
so.

The  issue, subscription or purchase of shares or other financial instruments in
the  Company is subject to specific  legal or regulatory restrictions in certain
jurisdictions. The Company does not assume any responsibility in the event there
is  a violation  by any  person of  such restrictions.  The distribution of this
release  may in certain  jurisdictions be restricted  by law. Persons into whose
possession  this release  comes should  inform themselves  about and observe any
such  restrictions. Any failure to comply with these restrictions may constitute
a violation of the securities laws of any such jurisdiction.

Matters   discussed   in   this   announcement  may  constitute  forward-looking
statements.  Forward-looking statements  are statements  that are not historical
facts  and may be identified by words such as "believe", "expect", "anticipate",
"strategy",  "intends",  "estimate",  "will",  "may",  "continue",  "should" and
similar  expressions. Any forward-looking  statements in this  release are based
upon  various  assumptions,  many  of  which  are  based,  in turn, upon further
assumptions.  Such assumptions are  inherently subject to  significant known and
unknown  risks, uncertainties,  contingencies and  other important factors which
are difficult or impossible to predict. Such risks, uncertainties, contingencies
and  other important factors could cause actual events to differ materially from
the  expectations expressed or  implied in this  release by such forward-looking
statements.  The  Company  does  not  make  any  guarantee  that the assumptions
underlying  any forward-looking  statements in  this announcement  are free from
errors  nor does  it accept  any responsibility  for the  future accuracy of the
opinions  expressed in this  announcement or any  obligation to update or revise
the statements in this announcement to reflect subsequent events. You should not
place undue reliance on any forward-looking statements in this announcement. The
information,   opinions   and   forward-looking  statements  contained  in  this
announcement  speak  only  as  at  its  date,  and are subject to change without
notice.  The  Company  does  not  undertake  any  obligation  to review, update,
confirm,  or to release publicly any revisions to any forward-looking statements
to  reflect events  that occur  or circumstances  that arise  in relation to the
content of this announcement.

This  announcement is made  by and, and  is the responsibility  of, the Company.
This  announcement is for information purposes only and is not to be relied upon
in  substitution for the exercise of independent judgment. It is not intended as
investment  advice and under no circumstances is  it to be used or considered as
an  offer to  sell, or  a solicitation  of an  offer to  buy any securities or a
recommendation to buy or sell any securities of the Company. The distribution of
this  announcement and  other information  may be  restricted by  law in certain
jurisdictions.  Persons into  whose possession  this announcement  or such other
information  should come are required to  inform themselves about and to observe
any  such  restrictions.  This  announcement  is  an  advertisement and is not a
prospectus  for the purposes of the  Prospectus Regulation as implemented in any
Member State.